Table 2: Clinical data.
Pre-APRV Mode PRVC PC PS Unknown MAWP FiO2 |
n (%) 30 (44.77) 8 (11.94) 23 (34.32) 6 (8.95) n, (SD) 63, 15.03 (5.75) 65, 70.98 (22.08) |
Pre-APRV Initiation: SpO2 P/F ratio1 Pre-APRV OI2 Pre-APRV OSI3 Pre-APRV MSOFA4 |
n ( ; min-max, SD) 67 (93.46; 78.00-100.00, 4.98) 44 (96.39; 26.00-222.50, 44.09) 43 (27.34; 5.42-88.46, 14.55) 63 (18.99, 6.73-75.00, 9.67) 58 (8.96, 2.00-17.00, 3.20) |
APRV Initial Parameters: Thigh, sec Tlow, sec Phigh, cmH2O Plow, cmH2O MAWP, cmH2O |
n ( ; min-max, SD) 65 (6.30; 0.90-11.00, 2.65) 61 (1.21; 0.40-10.00, 1.41) 65 (24.2; 18.00-35.00, 3.33) 68 (3.51; 0.00-15.00, 4.47) 66 (21.87; 4.00-31.00, 4.28) |
Post-APRV Dosing Total Time on APRV,hrs SpO2 P/F ratio1 Post-APRV OI2 Post-APRV OSI3 Post-APRV MSOFA4 |
n ( ; min-max, SD) 68 (19.27; 6.80-24.96, 5.49) 68 (93.51; 70.00-100.00, 5.47) 21 (147.27; 33.75-300.00, 71.63) 21 (19.81; 4.19-56.29, 14.12) 68 (12.27; 1.68-26.66, 5.75) 58 (8.79; 2.00-17.00, 3.16) |
1PaO2/FiO2; 2Oxygen Index = (FiO2*MAWP)/PaO2*100;
3Oxygen Saturation Index = (FiO2*MAWP)/SpO2*100; 4Modified Sequential Organ Failure Assessment Score.